The persistency of high levels of pSTAT3 expression in circulating CD4+ T cells from CIS patients favors the early conversion to clinically defined multiple sclerosis

Giovanni Frisullo; Viviana Nociti; Raffaele Iorio; Agata Katia Patanella; Alessandro Marti; Massimiliano Mirabella; Pietro Attilio Tonali; Anna Paola Batocchi

doi:10.1016/j.jneuroim.2008.09.003

The persistency of high levels of pSTAT3 expression in circulating CD4+ T cells from CIS patients favors the early conversion to clinically defined multiple sclerosis

Giovanni Frisullo, Viviana Nociti, Raffaele Iorio, Agata Katia Patanella, Alessandro Marti, Massimiliano Mirabella, Pietro Attilio Tonali, Anna Paola Batocchi

Fondazione Don Carlo Gnocchi Onlus

Research output: Contribution to journal › Article › peer-review

Abstract

Not all patients with clinically isolated syndrome (CIS) suggestive of multiple sclerosis (MS) develop clinically defined MS (CDMS). At first clinical event we observed increased production of IL17, IFNγ and IL10 by peripheral blood mononuclear cells from patients with CIS that remained high in remission. In CD4+ T cells pSTAT3 expression was higher in patients who subsequently converted to CDMS than in patients who did not and controls. The persistency of high levels of pSTAT3 in circulating CD4+ T cells from CIS patients after the first clinical event may favor the early conversion to CDMS.

Original language	English
Pages (from-to)	126-134
Number of pages	9
Journal	Journal of Neuroimmunology
Volume	205
Issue number	1-2
DOIs	https://doi.org/10.1016/j.jneuroim.2008.09.003
Publication status	Published - Dec 15 2008

Keywords

Clinically isolated syndrome
IFNγ
IL17
STAT1
STAT3
T-bet

ASJC Scopus subject areas

Immunology
Clinical Neurology
Immunology and Allergy
Neurology

Access to Document

10.1016/j.jneuroim.2008.09.003

Cite this

Frisullo, G., Nociti, V., Iorio, R., Patanella, A. K., Marti, A., Mirabella, M., Tonali, P. A., & Batocchi, A. P. (2008). The persistency of high levels of pSTAT3 expression in circulating CD4+ T cells from CIS patients favors the early conversion to clinically defined multiple sclerosis. Journal of Neuroimmunology, 205(1-2), 126-134. https://doi.org/10.1016/j.jneuroim.2008.09.003

The persistency of high levels of pSTAT3 expression in circulating CD4+ T cells from CIS patients favors the early conversion to clinically defined multiple sclerosis. / Frisullo, Giovanni; Nociti, Viviana; Iorio, Raffaele; Patanella, Agata Katia; Marti, Alessandro; Mirabella, Massimiliano; Tonali, Pietro Attilio; Batocchi, Anna Paola.

In: Journal of Neuroimmunology, Vol. 205, No. 1-2, 15.12.2008, p. 126-134.

Research output: Contribution to journal › Article › peer-review

Frisullo, G, Nociti, V, Iorio, R, Patanella, AK, Marti, A, Mirabella, M, Tonali, PA & Batocchi, AP 2008, 'The persistency of high levels of pSTAT3 expression in circulating CD4+ T cells from CIS patients favors the early conversion to clinically defined multiple sclerosis', Journal of Neuroimmunology, vol. 205, no. 1-2, pp. 126-134. https://doi.org/10.1016/j.jneuroim.2008.09.003

Frisullo, Giovanni ; Nociti, Viviana ; Iorio, Raffaele ; Patanella, Agata Katia ; Marti, Alessandro ; Mirabella, Massimiliano ; Tonali, Pietro Attilio ; Batocchi, Anna Paola. / The persistency of high levels of pSTAT3 expression in circulating CD4+ T cells from CIS patients favors the early conversion to clinically defined multiple sclerosis. In: Journal of Neuroimmunology. 2008 ; Vol. 205, No. 1-2. pp. 126-134.

@article{da1454d2b8d54cd19e15f80ff985941a,

title = "The persistency of high levels of pSTAT3 expression in circulating CD4+ T cells from CIS patients favors the early conversion to clinically defined multiple sclerosis",

abstract = "Not all patients with clinically isolated syndrome (CIS) suggestive of multiple sclerosis (MS) develop clinically defined MS (CDMS). At first clinical event we observed increased production of IL17, IFNγ and IL10 by peripheral blood mononuclear cells from patients with CIS that remained high in remission. In CD4+ T cells pSTAT3 expression was higher in patients who subsequently converted to CDMS than in patients who did not and controls. The persistency of high levels of pSTAT3 in circulating CD4+ T cells from CIS patients after the first clinical event may favor the early conversion to CDMS.",

keywords = "Clinically isolated syndrome, IFNγ, IL17, STAT1, STAT3, T-bet",

author = "Giovanni Frisullo and Viviana Nociti and Raffaele Iorio and Patanella, {Agata Katia} and Alessandro Marti and Massimiliano Mirabella and Tonali, {Pietro Attilio} and Batocchi, {Anna Paola}",

year = "2008",

month = dec,

day = "15",

doi = "10.1016/j.jneuroim.2008.09.003",

language = "English",

volume = "205",

pages = "126--134",

journal = "Journal of Neuroimmunology",

issn = "0165-5728",

publisher = "Elsevier Science B.V.",

number = "1-2",

}

TY - JOUR

T1 - The persistency of high levels of pSTAT3 expression in circulating CD4+ T cells from CIS patients favors the early conversion to clinically defined multiple sclerosis

AU - Frisullo, Giovanni

AU - Nociti, Viviana

AU - Iorio, Raffaele

AU - Patanella, Agata Katia

AU - Marti, Alessandro

AU - Mirabella, Massimiliano

AU - Tonali, Pietro Attilio

AU - Batocchi, Anna Paola

PY - 2008/12/15

Y1 - 2008/12/15

N2 - Not all patients with clinically isolated syndrome (CIS) suggestive of multiple sclerosis (MS) develop clinically defined MS (CDMS). At first clinical event we observed increased production of IL17, IFNγ and IL10 by peripheral blood mononuclear cells from patients with CIS that remained high in remission. In CD4+ T cells pSTAT3 expression was higher in patients who subsequently converted to CDMS than in patients who did not and controls. The persistency of high levels of pSTAT3 in circulating CD4+ T cells from CIS patients after the first clinical event may favor the early conversion to CDMS.

AB - Not all patients with clinically isolated syndrome (CIS) suggestive of multiple sclerosis (MS) develop clinically defined MS (CDMS). At first clinical event we observed increased production of IL17, IFNγ and IL10 by peripheral blood mononuclear cells from patients with CIS that remained high in remission. In CD4+ T cells pSTAT3 expression was higher in patients who subsequently converted to CDMS than in patients who did not and controls. The persistency of high levels of pSTAT3 in circulating CD4+ T cells from CIS patients after the first clinical event may favor the early conversion to CDMS.

KW - Clinically isolated syndrome

KW - IFNγ

KW - IL17

KW - STAT1

KW - STAT3

KW - T-bet

UR - http://www.scopus.com/inward/record.url?scp=56349095790&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=56349095790&partnerID=8YFLogxK

U2 - 10.1016/j.jneuroim.2008.09.003

DO - 10.1016/j.jneuroim.2008.09.003

M3 - Article

C2 - 18926576

AN - SCOPUS:56349095790

VL - 205

SP - 126

EP - 134

JO - Journal of Neuroimmunology

JF - Journal of Neuroimmunology

SN - 0165-5728

IS - 1-2

ER -

The persistency of high levels of pSTAT3 expression in circulating CD4+ T cells from CIS patients favors the early conversion to clinically defined multiple sclerosis

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this